Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 5,362 | 709 | 299 | 71,793 | 0 |
| Gross Profit | 5,362 | 709 | 299 | 71,793 | N/A |
| Operating Expenses | 182,567 | 184,927 | 197,374 | 151,292 | 164,186 |
| Operating Income | -177,205 | -184,218 | -197,075 | -79,499 | -164,186 |
| Other Income | 760 | -4,168 | -2,545 | 2,744 | -2,244 |
| Pre-tax Income | -176,445 | -188,386 | -199,620 | -76,755 | -166,430 |
| Income Tax | N/A | N/A | N/A | 3,299 | N/A |
| Net Income Continuous | -176,445 | -188,386 | -199,620 | -80,054 | -166,430 |
| Net Income | $-176,445 | $-188,386 | $-199,620 | $-80,054 | $-166,430 |
| EPS Basic Total Ops | -3.18 | -3.40 | -3.76 | -1.55 | -3.23 |
| EPS Basic Continuous Ops | -3.18 | -3.40 | -3.76 | -1.55 | -3.23 |
| EPS Diluted Total Ops | -3.18 | -3.40 | -3.76 | -1.55 | -3.23 |
| EPS Diluted Continuous Ops | -3.18 | -3.40 | -3.76 | -1.55 | -3.23 |
| EPS Diluted Before Non-Recurring Items | -3.18 | -3.40 | -3.72 | N/A | N/A |
| EBITDA(a) | $-176,037 | $-182,607 | $-195,314 | $-77,707 | $-162,551 |